A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment ...

Lean Drops, an innovative liquid dietary supplement targeting metabolic function and appetite regulation, has officially ...

Vimgreen Pharmaceuticals, a leading innovator in adenosine signaling modulation, today announced the approval of its ...

Taking magnesium with a GLP-1 like Ozempic? Learn how they can interact, potential digestive effects, and key safety tips.

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...

Drugs based on semaglutide have become some of the most talked-about medicines in recent years. These drugs belong to a class ...

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

Ivim Health reports that peptide therapies, spurred by GLP-1 interest, require careful understanding and medical oversight for safe use.

Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg ...